menu
    • menu

    Company profile for Biolojic Design

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Powered by AI, Biolojic's technology designs single and multi-specific antibodies precisely targeting predefined epitopes to execute novel biological programs. Focusing on diseases that involve the immune system, Biolojic develops a pipeline of antibodies that are designed to unlock the full potential of we...
    Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Powered by AI, Biolojic's technology designs single and multi-specific antibodies precisely targeting predefined epitopes to execute novel biological programs. Focusing on diseases that involve the immune system, Biolojic develops a pipeline of antibodies that are designed to unlock the full potential of well-studied pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biolojic DesignUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Boston, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biolojic.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biolojic Design Presents New Preclinical Data for BD200
    Biolojic Design Presents New Preclinical Data for BD200

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187982

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Biolojic Design Unveils Preclinical Data On BD200, At AACR
    Biolojic Design Unveils Preclinical Data On BD200, At AACR

    17 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/17/3276452/0/en/Biolojic-Design-Presents-New-Preclinical-Data-for-BD200-a-First-in-Class-Multibody-Drug-Conjugate-Targeting-Trop-2-and-Nectin-4-at-the-American-Association-of-Cancer-Research-Annua.html

    GLOBENEWSWIRE
    17 Apr 2026
    Share Share
    Biolojic Earns Teva Milestone for First AI Multibody TEV '325
    Biolojic Earns Teva Milestone for First AI Multibody TEV '325

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262066/0/en/Biolojic-Design-Earns-Preclinical-Milestone-from-Teva-for-First-AI-Designed-Multibody-in-Autoimmune-Disease-TEV-325-formerly-BD9.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Biolojic Design Appoints Roger Waltzman As Chief Medical Officer
    Biolojic Design Appoints Roger Waltzman As Chief Medical Officer

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213561/0/en/Biolojic-Design-Appoints-Roger-Waltzman-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Teva, Biolojic Begin IND Studies for BD9 in Asthma, Dermatitis
    Teva, Biolojic Begin IND Studies for BD9 in Asthma, Dermatitis

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088603/0/en/Teva-and-Biolojic-Design-Initiate-IND-enabling-Studies-of-BD9-a-Multibody-Designed-to-Explore-the-Treatment-of-Atopic-Dermatitis-and-Asthma.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Biolojic Design Appoints Neal Curran as Chief Business Officer
    Biolojic Design Appoints Neal Curran as Chief Business Officer

    21 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/21/2985148/0/en/Biolojic-Design-Appoints-Neal-Curran-as-Chief-Business-Officer.html

    GLOBENEWSWIRE
    21 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search